Results 181 to 190 of about 4,974,366 (288)

‘More than information’: A social listening and platform architecture analysis of online special educational needs and disabilities discourse

open access: yesBritish Educational Research Journal, EarlyView.
Abstract Parents of children with special educational needs and disabilities (SEND) increasingly seek information and support through online discussions, yet little is known about how architectural features of digital platforms shape the interactions and support that parents encounter. The paper makes two contributions: First, it develops and applies a
Alan Shaw, Patricia A. Shaw
wiley   +1 more source

Climate assemblies involving children and youth as socio‐educational spaces: Perceived success factors, challenges and opportunities

open access: yesBritish Educational Research Journal, EarlyView.
Abstract Climate assemblies have emerged as participatory mechanisms and as socio‐educational spaces for engaging citizens in climate decision‐making and promoting sustainability learning. However, to date, initiatives involving children and young people remain underexplored.
Gisela Cebrián, Justin Dillon
wiley   +1 more source

How curriculum modifications shape educational pathways: Evidence from linked administrative data in Switzerland

open access: yesBritish Educational Research Journal, EarlyView.
Abstract The increasing heterogeneity of learning needs and preconditions in inclusive mainstream classrooms entails that not all learners are equally able to meet the regular learning objectives. In response, various integrative measures have been implemented to tailor instruction to students' individual needs.
Robin Benz   +2 more
wiley   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

open access: yesBiotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy